A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

E. J. Rhee; W. Y. Lee; K. H. Yoon; S. J. Yoo; I. K. Lee; S. H. Baik; Y. K. Kim; M. K. Lee; K. S. Park; J. Y. Park; B. S. Cha; H. W. Lee; K. W. Min; H. Y. Bae; M. J. Kim; J. A. Kim; D. K. Kim; S. W. Kim

首页> 外文期刊>Diabetes, Obesity and Metabolism >A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

【24h】

A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

机译：一项多中心，随机，安慰剂对照，双盲II期临床试验，评估LC 15-0444对2型糖尿病患者的最佳剂量，疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim: The objective of this study was to evaluate the optimal dose, efficacy and safety of a novel dipeptidyl peptidase-4 (DPP-IV) inhibitor, LC15-0444, in Korean subjects with type 2 diabetes mellitus treated by diet and exercise.

机译：目的：本研究的目的是评估饮食和运动治疗的韩国2型糖尿病患者中新型二肽基肽酶4（DPP-IV）抑制剂LC15-0444的最佳剂量，疗效和安全性。

著录项

来源
《Diabetes, Obesity and Metabolism》 |2010年第12期|1113-1119|共7页
作者
E. J. Rhee; W. Y. Lee; K. H. Yoon; S. J. Yoo; I. K. Lee; S. H. Baik; Y. K. Kim; M. K. Lee; K. S. Park; J. Y. Park; B. S. Cha; H. W. Lee; K. W. Min; H. Y. Bae; M. J. Kim; J. A. Kim; D. K. Kim; S. W. Kim;
展开▼
作者单位

Department of Internal Medicine Kangbuk Samsung Hospital Sungkyunkwan University School of Medicine Seoul Korea;

Seoul St. Mary's Hospital The Catholic University of Korea Seoul Korea;

Bucheon St. Mary's Hospital The Catholic University of Korea Bucheon Korea;

Kyungpook National University Hospital Daegu Korea;

Korea University Guro Hospital Seoul Korea;

Pusan National University Hospital Pusan Korea;

Samsung Medical Center Samsung Life Public Welfare Foundation Seoul Korea;

Seoul National University Hospital Seoul Korea;

Asan Medical Center Asan Public Welfare Foundation University of Ulsan College of Medicine Seoul Korea;

Severance Hospital Yonsei University Medical College of Medicine Seoul Korea;

Yeungnam University Medical Center Seoul Korea;

Eulji Medical Center Medical Corporation Seoul Korea;

Chosun University Hospital Seoul Korea;

LG Life Science Seoul Korea;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
dose-finding study; DPP-IV inhibitor; monotherapy; type 2 diabetes;

机译：剂量研究;DPP-IV抑制剂;单一疗法;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes. [J] . Rhee EJ, Lee WY, Yoon KH, Diabetes, obesity & metabolism . 2010,第12期

机译：一项多中心，随机，安慰剂对照，双盲II期临床试验，评估LC 15-0444对2型糖尿病患者的最佳剂量，疗效和安全性。
2. A multicentre, multinational, randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of gemigliptin (LC15-0444) in patients with type 2 diabetes [J] . Diabetes, obesity & metabolism . 2013,第5期

机译：一项多中心，跨国，随机，安慰剂对照，双盲，3期临床试验，评估吉西格列汀（LC15-0444）在2型糖尿病患者中的疗效和安全性
3. Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial [J] . Shimoyama Naohito, Gomyo Ikuo, Katakami Nobuyuki, International journal of clinical oncology . 2015,第1期

机译：滴定剂量的舌下芬太尼口腔崩解片治疗日本癌症患者突破性疼痛的疗效和安全性：一项多中心，随机，安慰剂对照，双盲III期临床试验
4. A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED CLINICAL TRIAL TO INVESTIGATE THE EFFICACY OF TIAMULIN IN THE CONTROL OF PORCINE PROLIFERATIVE ENTEROPATHY (PPE) AND PORCINE COLONIC SPIROCHAETOSIS (PCS) UNDER FIELD CONDITIONS [C] . J. Haugegaard, K. Moller, T.K. Jensen, Congress of the International Pig Veterinary Society . 2000

机译：一种双盲随机安慰剂对照临床试验，探讨硫霉素在野生植物中猪增殖肠病（PPE）和猪结肠螺旋肌肤症（PCS）的疗效
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. A Phase II Double-Blind Randomized Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes [O] . Yael Lebenthal, Avivit Brener, Eli Hershkovitz, 2019

机译：II期双盲随机安慰剂对照多中心研究评估Alpha-1抗胰蛋白酶（AAT）（Glassia®）在治疗近期发病的1型糖尿病中的疗效和安全性
7. Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial [O] . Julie DUBOURG, Pascale FOUQUERAY, Carole THANG, 2021

机译：IMEGLIMIN单疗法对2型糖尿病患者的安慰剂的疗效和安全性（时间1）：双盲，随机，安慰剂控制，并联组，多中心3阶段试验

A multicenter, randomized, placebo-controlled, double-blind phase II trial evaluating the optimal dose, efficacy and safety of LC 15-0444 in patients with type 2 diabetes

摘要

著录项

相似文献

相关主题

期刊订阅